Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Alterations in prothrombin time and activated partial thromboplastin time in patients with acute myocardial infarction.

Khan HA, Alhomida AS, Rammah TY, Sobki SH, Ola MS, Khan AA.

Int J Clin Exp Med. 2013 Apr 12;6(4):294-7. Print 2013.

3.
5.

Effect of warfarin on the activated partial thromboplastin time.

Hauser VM, Rozek SL.

Drug Intell Clin Pharm. 1986 Dec;20(12):964-7.

PMID:
3816546
7.
8.

Changes in prothrombin and activated partial thromboplastin time during replacement therapy with human recombinant growth hormone in growth hormone deficient adults.

Miljic D, Miljic P, Doknic M, Pekic S, Djurovic M, Colovic M, Popovic V.

Hormones (Athens). 2006 Jul-Sep;5(3):187-91.

9.

Multicentric evaluation of heparinase on aPTT, thrombin clotting time and a new PT reagent based on recombinant human tissue factor.

Harenberg J, Reichel T, Malsch R, Hirsh J, Rustagi P.

Blood Coagul Fibrinolysis. 1996 Jun;7(4):453-8.

PMID:
8839997
10.

Intraoperative measurement of activated partial thromboplastin time and prothrombin time by a portable laser photometer in patients following cardiopulmonary bypass.

Nuttall GA, Oliver WC Jr, Beynen FM, Dull JJ, Murray MJ, Nichols WL.

J Cardiothorac Vasc Anesth. 1993 Aug;7(4):402-9.

PMID:
8400094
11.

Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study.

Testa S, Legnani C, Tripodi A, Paoletti O, Pengo V, Abbate R, Bassi L, Carraro P, Cini M, Paniccia R, Poli D, Palareti G.

J Thromb Haemost. 2016 Nov;14(11):2194-2201. doi: 10.1111/jth.13486. Epub 2016 Oct 15.

PMID:
27566988
12.

[Effect of hydrogen sulfide on tissue factor-induced disseminated intravascular coagulation in rabbits].

Lu X, Li W, Wang G, Wang Q, Jiang Y, Gao J, Zhao X, Xu L.

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 Feb;27(2):92-6. doi: 10.3760/cma.j.issn.2095-4352.2015.02.003. Chinese.

13.

An assessment of the utility of unselected coagulation screening in general hospital practice.

McHugh J, Holt C, O'Keeffe D.

Blood Coagul Fibrinolysis. 2011 Mar;22(2):106-9. doi: 10.1097/MBC.0b013e3283432fb7.

PMID:
21245744
14.

Stability of prothrombin time and activated partial thromboplastin time tests under different storage conditions.

Rao LV, Okorodudu AO, Petersen JR, Elghetany MT.

Clin Chim Acta. 2000 Oct;300(1-2):13-21.

PMID:
10958859
15.
16.

Retrospective evaluation of shortened prothrombin time or activated partial thromboplastin time for the diagnosis of hypercoagulability in dogs: 25 cases (2006-2011).

Song J, Drobatz KJ, Silverstein DC.

J Vet Emerg Crit Care (San Antonio). 2016 May;26(3):398-405. doi: 10.1111/vec.12478. Epub 2016 Apr 13.

PMID:
27074596
17.

Standardization of coagulation tests.

Opartkiattikul N.

Southeast Asian J Trop Med Public Health. 1999;30 Suppl 3:79-85.

PMID:
10926265
18.
19.

Determination of normal versus abnormal activated partial thromboplastin time and prothrombin time after cardiopulmonary bypass.

Nuttall GA, Oliver WC, Beynen FM, Santrach PJ, Strickland RA, Murray MJ.

J Cardiothorac Vasc Anesth. 1995 Aug;9(4):355-61.

PMID:
7579102
20.

Supplemental Content

Support Center